dihydroxyphenylalanine has been researched along with lithium in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (94.87) | 18.7374 |
| 1990's | 2 (5.13) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauffe, L; Friedman, M; Windle, JJ | 1 |
| Campbell, M | 1 |
| Tissot, R | 1 |
| Alekseeva, LP; Saratikov, AS; Spiridonova, ZI | 1 |
| Dupont, AG; Schoors, DF | 1 |
| Girbes, AR; Meijer, S; Reitsma, WD; Smit, AJ | 1 |
| Brown, J; Jeffrey, RF; Lee, MR; Macdonald, TM; Rae, PW | 1 |
| Cahill, AL; Horwitz, J; Perlman, RL | 1 |
| Koyama, T | 1 |
| Gudelsky, GA; Koenig, JI; Koyama, T; Meltzer, HY | 1 |
| Ambani, LM; Van Woert, MH | 1 |
| Dalén, P; Steg, G | 1 |
| Leijnse-Ybema, HJ; Schenk, G | 1 |
| McCaul, JA; Stern, GM | 1 |
| Bunney, WE; Goodwin, FK; Murphy, DL | 2 |
| Cramer, H; Goodwin, FK; Paul, MI | 2 |
| Vinar, O | 1 |
| Creveling, CR; Daly, J; Morris, N; Ong, HH; Shimizu, H | 1 |
| Goodwin, FK; Sack, R | 1 |
| Nagai, K; Yamauchi, Y | 1 |
| Stancer, HC | 1 |
| Schildkraut, JJ | 1 |
| Chazot, G; Courjon, J; Moene, Y; Setiey, A; Trillet, M | 1 |
| Biron, P; Latour, R | 1 |
| Henry, GM; Murphy, DL; Weingartner, H | 1 |
| Eichelman, BS; Thoa, NB | 1 |
| Bora, SS; Radichevich, I; Werner, SC | 1 |
| Matussek, N | 1 |
| Pearlman, CA | 1 |
| Bertolino, A; Kemali, D; Lamura, G; Longo, V; Pacini, A | 1 |
| Nordgren, L | 1 |
| De Haen, P | 1 |
| Ryback, RS; Schwab, RS | 1 |
| Andelman, R; Mokrasch, LC | 1 |
| Horwitz, J; Perlman, RL; Tsymbalov, S | 1 |
| Berggren, U; Engel, J | 1 |
| Ahlenius, S; Berggren, U; Engel, J | 1 |
4 review(s) available for dihydroxyphenylalanine and lithium
| Article | Year |
|---|---|
The common pathophysiology of monaminergic psychoses: a new hypothesis.
Topics: 5-Hydroxytryptophan; Amino Acids; Biological Transport, Active; Bipolar Disorder; Blood-Brain Barrier; Brain; Catecholamines; Clomipramine; Dihydroxyphenylalanine; Dopamine; Electroconvulsive Therapy; Humans; Lithium; Lysergic Acid Diethylamide; Models, Biological; Monoamine Oxidase Inhibitors; Psychotic Disorders; Schizophrenia; Serotonin; Tranquilizing Agents; Tryptophan; Tyrosine | 1975 |
[Clinical psychopharmacology in 1971].
Topics: Amphetamine; Antidepressive Agents; Antiparkinson Agents; Chemical Phenomena; Chemistry; Chlorpromazine; Czechoslovakia; Dihydroxyphenylalanine; Hallucinogens; Humans; Hypnotics and Sedatives; Lithium; Lysergic Acid Diethylamide; Mental Disorders; Psychoses, Substance-Induced; Sleep, REM; Thiothixene; Tranquilizing Agents | 1972 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyphenylalanine; Drug Industry; Electroconvulsive Therapy; Humans; Imipramine; Lithium; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nicotinic Acids; Psychopharmacology; Research Support as Topic; Schizophrenia; Tranquilizing Agents; Tryptophan; Vitamins | 1973 |
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
Topics: Adult; Aged; Catechol O-Methyltransferase; Depression; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Erythrocytes; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Sleep; Thyroid Gland | 1974 |
5 trial(s) available for dihydroxyphenylalanine and lithium
| Article | Year |
|---|---|
Pharmacotherapy in early infantile autism.
Topics: Adolescent; Amphetamines; Anticonvulsants; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autistic Disorder; Child; Child, Preschool; Chlordiazepoxide; Clinical Trials as Topic; Cognition; Dihydroxyphenylalanine; Diphenhydramine; Hallucinogens; Humans; Hypnotics and Sedatives; Intelligence; Lithium; Prognosis; Triiodothyronine; Vitamins | 1975 |
Lithium and the renal response to gludopa, fenoldopam and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Drug Interactions; Fenoldopam; Humans; Kidney Tubules, Proximal; Lithium; Natriuresis; Receptors, Dopamine | 1990 |
Letter: Lithium in Parkinson's disease.
Topics: Carbonates; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Antagonism; Drug Evaluation; Drug Therapy, Combination; Humans; Lithium; Movement Disorders; Parkinson Disease | 1974 |
Artifactual elevation of PBI from an iodinated dye used to stain medicinal capsules pink.
Topics: Bipolar Disorder; Blood Proteins; Capsules; Carbonates; Chromatography, Paper; Clinical Trials as Topic; Dihydroxyphenylalanine; Diiodotyrosine; Fluoresceins; Humans; Iodine; Iodoproteins; Lithium; Monoiodotyrosine; Parkinson Disease; Protein Binding; Thyroxine; Triiodothyronine | 1969 |
Clinical and animal experiments concerning the function of brain catecholamines.
Topics: Animals; Antidepressive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Catecholamines; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Dopamine; Form Perception; Humans; Lithium; Locomotion; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Placebos; Rats; Reaction Time; Reserpine; Schizophrenia; Serotonin; Stimulation, Chemical; Time Factors; Tyrosine | 1971 |
30 other study(ies) available for dihydroxyphenylalanine and lithium
| Article | Year |
|---|---|
Electron spin resonance study of melanin treated with reducing agents.
Topics: Ammonia; Animals; Catechol Oxidase; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Electron Spin Resonance Spectroscopy; Hydrolysis; Lithium; Melanins; Oxidation-Reduction; Papain; Wool | 1975 |
[The effect of lithium on the concentration of catecholamines in the brains of rabbits and rats].
Topics: Amygdala; Animals; Brain Chemistry; Catecholamines; Caudate Nucleus; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hippocampus; Hypothalamus; Lithium; Male; Motor Cortex; Norepinephrine; Rabbits; Rats; Reticular Formation; Stimulation, Chemical; Thalamus | 1975 |
Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Drug Interactions; Fenoldopam; Humans; Kidney Tubules, Proximal; Lithium; Natriuresis; Receptors, Dopamine | 1990 |
The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.
Topics: Adult; Atrial Natriuretic Factor; Cyclic AMP; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Hemodynamics; Humans; Kidney; Lithium; Male; Middle Aged; Prodrugs; Renin; Sodium | 1988 |
Low-Na+ medium increases the activity and the phosphorylation of tyrosine hydroxylase in the superior cervical ganglion of the rat.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amiloride; Animals; Chlorides; Dihydroxyphenylalanine; Ethers; Gallopamil; Ganglia, Sympathetic; Ionomycin; Lithium; Lithium Chloride; Male; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin; Tyrosine 3-Monooxygenase | 1985 |
[The effect of lithium treatment on the activity of central dopaminergic neurons].
Topics: Animals; Brain; Catecholamines; Dihydroxyphenylalanine; Dopamine; Lithium; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine | 1987 |
Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Lithium; Median Eminence; Neurons; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains | 1988 |
Lithium and levodopa in parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Lithium; Parkinson Disease | 1973 |
Lithium and levodopa in parkinsonism.
Topics: Dihydroxyphenylalanine; Female; Humans; Hyperkinesis; Lithium; Male; Parkinson Disease | 1973 |
Letter: Huntington's chorea and levodopa.
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Lithium; Male; Phenylacetates | 1974 |
Clinical and pharmacological investigations of the psychobiology of the affective disorders.
Topics: Antidepressive Agents; Behavior; Bipolar Disorder; Catecholamines; Depression; Dihydroxyphenylalanine; Humans; Lithium; Methyltyrosines; MMPI; Sleep; Sleep, REM; Time Factors | 1971 |
Urinary cyclic A.M.P. in affective illness.
Topics: Adenine Nucleotides; Bipolar Disorder; Cyclic AMP; Dihydroxyphenylalanine; Humans; Lithium | 1970 |
Urinary cyclic AMP excretion in depression and mania. Effects of levodopa and lithium carbonate.
Topics: Acute Disease; Adenine Nucleotides; Adult; Affective Symptoms; Bipolar Disorder; Cyclic AMP; Depression; Dihydroxyphenylalanine; Female; Humans; Lithium; Middle Aged | 1971 |
Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols.
Topics: Aluminum; Animals; Catechol O-Methyltransferase; Catechols; Chemical Phenomena; Chemistry; Chromatography, Gas; Chromatography, Thin Layer; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hydrogen-Ion Concentration; Hydrolysis; Lithium; Liver; Methylation; Methyldopa; Methyltransferases; Norepinephrine; Normetanephrine; Oxidation-Reduction; Periodic Acid; Rats; Stereoisomerism; Structure-Activity Relationship | 1972 |
Proceedings: The "pharmacological bridge": a view from the clinical shores.
Topics: Affective Symptoms; Antidepressive Agents; Catecholamines; Dihydroxyphenylalanine; Humans; Lithium; Monoamine Oxidase Inhibitors | 1974 |
Proceedings: Effect of lithium salt on the L-DOPA transport system.
Topics: Animals; Biological Transport; Brain; Dihydroxyphenylalanine; Guinea Pigs; In Vitro Techniques; Lithium; Synaptosomes | 1974 |
[Unusual clinical and electroencephalographic aspects induced by lithium-dopa association].
Topics: Aged; Brain; Cognition Disorders; Coma; Dihydroxyphenylalanine; Electroencephalography; Female; Humans; Lithium; Myoclonus; Parkinson Disease | 1972 |
[Five new drugs offered in 1970].
Topics: Benzazepines; Carbonates; Dihydroxyphenylalanine; Flurazepam; Hypnotics and Sedatives; Ketamine; Lithium; Mesoridazine | 1972 |
Influence of affective states and psychoactive drugs on verbal learning and memory.
Topics: Bipolar Disorder; Carbonates; Depression; Dihydroxyphenylalanine; Humans; Imipramine; Lithium; Memory; Methyltyrosines; Serial Learning; Tryptophan; Verbal Learning; Word Association Tests | 1973 |
The aggressive monoamines.
Topics: Aggression; Amines; Animals; Apomorphine; Appetitive Behavior; Behavior, Animal; Brain; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Electroshock; Fear; Humans; Hydroxydopamines; Hypothalamus; Lithium; Male; Models, Biological; Norepinephrine; Psychopharmacology; Rats; Rubidium | 1973 |
The "switch process" in manic-depressive illness. 3. Theoretical implications.
Topics: Biological Transport, Active; Bipolar Disorder; Brain; Brain Chemistry; Calcium; Carbonates; Catecholamines; Dihydroxyphenylalanine; Humans; Lithium; Magnesium; Neurons; Norepinephrine; Potassium; Receptors, Drug; Sodium; Substance-Related Disorders; Time Factors | 1972 |
Manic behavior and levodopa.
Topics: Bipolar Disorder; Dihydroxyphenylalanine; Humans; Lithium; Male; Middle Aged; Parkinson Disease | 1971 |
[Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
Topics: Basal Ganglia Diseases; Dihydroxyphenylalanine; Extrapyramidal Tracts; Humans; Lithium; Mental Disorders; Movement Disorders; Tranquilizing Agents | 1971 |
Effect of chlorpromazine, desmethylimipramine and lithium on dopamine uptake in the rat pancreas.
Topics: Animals; Chlorpromazine; Desipramine; Dihydroxyphenylalanine; Lithium; Pancreas; Rats | 1971 |
New drugs--recent releases.
Topics: Adrenal Cortex Hormones; Anesthetics; Dihydroxyphenylalanine; Humans; Hypnotics and Sedatives; Lithium; United States; United States Food and Drug Administration | 1971 |
Manic response to levodopa therapy. Report of a case.
Topics: Aged; Bipolar Disorder; Dihydroxyphenylalanine; Humans; Lithium; Male; Parkinson Disease; Psychoses, Substance-Induced | 1971 |
Non-enzymic incorporation of amines into proteolipid protein.
Topics: Amines; Animals; Carbon Isotopes; Cattle; Centrifugation; Chlorides; Choline; Chromatography, Gel; Chromatography, Paper; Dihydroxyphenylalanine; Histamine; Hydrogen-Ion Concentration; Lipoproteins; Lithium; Mescaline; Nerve Tissue Proteins; Protein Binding; Serotonin; Serum Albumin, Bovine; Tryptamines | 1968 |
Muscarine increases tyrosine 3-monooxygenase activity and phospholipid metabolism in the superior cervical ganglion of the rat.
Topics: Animals; Bethanechol Compounds; Calcium; Cyclic GMP; Deoxycholic Acid; Dihydroxyphenylalanine; Ganglia, Sympathetic; In Vitro Techniques; Lithium; Male; Muscarine; Phospholipids; Rats; Rats, Inbred Strains; Type C Phospholipases; Tyrosine 3-Monooxygenase | 1984 |
Effects of lithium on behaviour and central monoamines.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Catecholamines; Clonidine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Lithium; Locomotion; Mice; Motor Activity; Rats | 1980 |
Effects of acute lithium administration on conditioned avoidance behavior and monoamine synthesis in rats.
Topics: 5-Hydroxytryptophan; Animals; Avoidance Learning; Benzyl Alcohols; Corpus Striatum; Dihydroxyphenylalanine; Hydrazines; Limbic System; Lithium; Male; Rats; Tryptophan; Tyrosine | 1980 |